恩华药业：关于盐酸硫必利片通过仿制药一致性评价的公告

Core Viewpoint - Enhua Pharmaceutical has received approval from the National Medical Products Administration for the supplementary application of Sulpiride Hydrochloride Tablets, confirming that the drug meets the consistency evaluation of quality and efficacy for generic drugs [2] Group 1 - The approval notification was issued recently, indicating a positive regulatory development for the company [2] - The drug has successfully passed the consistency evaluation, which is crucial for generic medications in ensuring they are equivalent to their branded counterparts [2]